BHU Signs MoU with Russia’s Northern State Medical University to Boost Academic and Research Ties

IMT News Desk
IMT News Desk
· 2 min read
BHU signs MoU with Russia's Northern State Medical University to strengthen academic exchange, research collaboration, and student mobility in healthcare.

Banaras Hindu University (BHU), Varanasi, has signed a Memorandum of Understanding (MoU) with the Northern State Medical University (NSMU) of the Ministry of Health of the Russian Federation, marking a significant step towards strengthening bilateral academic, scientific, and cultural cooperation between the two institutions.

The agreement was formalised in the presence of BHU Vice-Chancellor Prof. Ajit Kumar Chaturvedi and senior representatives from both sides. BHU Registrar Prof. Arun Kumar Singh signed on behalf of the university, while Bylova N. A., Acting Rector, represented NSMU as the official signatory from the Russian side.

The MoU lays the groundwork for academic mobility through structured exchange programmes, collaborative research initiatives, and joint academic activities involving students, researchers, faculty, and technical staff. The two institutions have committed to jointly advancing scientific progress and building specialised human resources across medical and health sciences.

Speaking on the occasion, Vice-Chancellor Prof. Chaturvedi said the agreement opens new avenues of mutual collaboration, allowing both universities to leverage each other’s expertise, academic strengths, and institutional experiences. He also emphasised the need to explore internship opportunities for students from both institutions, enabling them to gain practical exposure and a broader international perspective in the field of medicine and healthcare.

Natalia Anikina, Dean of NSMU Russia, highlighted that the partnership would create new pathways for growth and excellence for students and staff on both sides. She noted that Northern State Medical University is already home to nearly 1,500 Indian students and offers advanced medical education and research infrastructure, making this collaboration a natural and mutually beneficial progression.

Read Next

India’s first focused health AI Conclave unites doctors and AI experts
Featured Article
July 10, 2026

India’s first focused health AI Conclave unites doctors and AI experts

• Global Healthcare Academy hosts HAI Conclave 2026, India’s first national platform dedicated to Healthcare and Artificial Intelligence • Landmark Bengaluru conference brings together healthcare leaders and AI experts to explore how Artificial Intelligence can make healthcare faster, safer and more accessible while keeping patients at the centre of every decision The inaugural edition of the HAI Conclave […]
Article by: IMT News Desk
Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026
News
July 10, 2026

Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026

Fischer Medical Ventures Limited (FMVL) has announced that its strategic partner, Nanyang Biologics, has achieved a major international milestone with its AI-powered molecular research platform, NYB.AI, being featured in the opening showcase at NVIDIA GTC Taiwan 2026, ahead of the keynote address by NVIDIA Founder and CEO Jensen Huang. The recognition places NYB.AI among a […]
Article by: IMT News Desk
Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs
News
July 10, 2026

Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs

Indian pharmaceutical companies are expected to report healthy revenue growth in the first quarter of FY27, but margins are likely to compress as sector profitability comes under pressure. In a recent preview note, Goldman Sachs said it anticipates around 185 basis points year-on-year margin decline for the sector in the June quarter, driven primarily by […]
Article by: IMT News Desk
Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue
News
July 10, 2026

Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue

Dr Reddy’s Laboratories has announced a delay in commercial supplies of its semaglutide product after certain batches were found to be out of specification due to an issue with the active pharmaceutical ingredient (API) used in the drug. The company said it has initiated an investigation into the root cause and is taking corrective measures […]
Article by: IMT News Desk